Skip to main content

Table 1 General information

From: Comparison of three digestive tract reconstruction methods for the treatment of Siewert II and III adenocarcinoma of esophagogastric junction: a prospective, randomized controlled study

Variables (n, %)PJIRSTR
(n = 98)
PJIRDTR
(n = 103)
TGRY
(n = 99)
P value
Male88 (89.80)90 (87.38)82 (82.83)0.345
Age (years)   0.458
 < 6025 (25.51)23 (22.33)18 (18.18) 
 ≥ 6073 (74.49)80 (77.67)18 (18.18) 
Differentiation   0.572
 High-middle60 (61.22)70 (67.96)66 (66.67) 
 Low38 (38.78)33 (32.04)33 (33.33) 
TNM stage   0.562
 I81 (82.65)87 (84.47)78 (78.79) 
 II17 (17.35)16 (15.53)21 (21.21) 
Siewert type   0.628
 II45 (45.92)48 (46.60)40 (40.40) 
 III53 (54.08)55 (53.40)59 (59.60) 
Clinical stage   0.562
 T1N0M0 stage IA61 (62.24)65 (63.11)63 (63.64) 
 T2N0M0 stage IB20 (20.41)22 (21.36)15 (15.15) 
 T3N0M0 stage II17 (17.35)16 (15.53)21 (21.21)